Early in 2022, the French legislature greenlighted the cultivation of cannabis inside French territory to supply the nation’s ongoing pilot program in medical marijuana. The clinical trials were launched in March 2021 with cannabis supplied from abroad and have been overseen by the country’s food and drug office, the Agence Nationale de Sécurité du Médicament, or the National Agency for the Safety of Medicines and Health Products.
This two-year pilot program consists of 3,000 patients in France using medical cannabis, something that’s been prohibited since 1953.
